1-5 of 5
Peter Moller, MD
Close
Sort by
Journal Articles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Trine Alma Knudsen, MD, Vibe Skov, PhD, Lillian Werner, MS, William Duke, Christopher J. Gibson, MD, Anwesha Nag, PhD, Aaron R. Thorner, PhD, Bruce Wollison, MS, Dennis Lund Hansen, MD, Thomas Stauffer Larsen, MD PhD, Christina Ellervik, MD PhD, Daniel El Fassi, MD, Karin de Stricker, MD, Lukas Frans Ocias, MD, Mette Brabrand, Ole Weis Bjerrum, MD PhD, Ulrik Malthe Overgaard, MD, Mikael Frederiksen, MD, Thomas Kielsgaard Kristensen, Torben A Kruse, Mads Thomassen, PhD, Torben Mourits-Andersen, MD, Marianne Tang Severinsen, MD PhD, Jesper Stentoft, MD, Joern Starklint, Peter Møller, MD, Donna S Neuberg, ScD, Lasse Kjær, PhD, Hans Hasselbalch, MD, R. Coleman Lindsley, MD PhD, Ann Mullally, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4202.
https://doi.org/10.1182/blood-2019-126164
Published: 2019
Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Trine Alma Knudsen, MD, Dennis Lund Hansen, MD, Lukas Frans Ocias, MD, Ole Weis Bjerrum, MD DMSc, Mette Brabrand, Daniel El Fassi, MD PhD, Mikael Frederiksen, MD, Lasse Kjær, PhD, Thomas Kielsgaard Kristensen, MSc, PhD, Torben A Kruse, Torben Mourits-Andersen, MD, Peter Møller, MD, Ulrik Malthe Overgaard, MD, Marianne Tang Severinsen, MD PhD, Vibe Skov, PhD, Jesper Stentoft, Professor, dr.MD, Jørn Starklint, MD, Karin de Stricker, MSc, PhD, Mads Thomassen, PhD, Thomas Stauffer Larsen, MD PhD, Hans Carl Hasselbalch, Professor, dr.MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 580.
https://doi.org/10.1182/blood-2018-99-111255
Published: 2018
Journal Articles

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Jorne Lionel Biccler, MSc, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MD PhD, Claus Werenberg Marcher, MD PhD, Peter Møller, MD, Claudia Schöllkopf, MD PhD, Lone Smidstrup Friis, MD PhD, Lasse Hjort Jakobsen, MSc, Tarec Christoffer El-Galaly, MD PhD, Jan M. Nørgaard, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2595.
https://doi.org/10.1182/blood.V130.Suppl_1.2595.2595
Published: 2017
Journal Articles

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Chuanhui Xu, Anke Van Den Berg, PhD, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, MD, Sibrand Poppema, MD, PhD, Lydia Visser
Journal: Blood
Blood (2009) 114 (22): 1551.
https://doi.org/10.1182/blood.V114.22.1551.1551
Published: 2009
Journal Articles

Biallelic Mutation of SOCS-1 Impairs JAK2 Degradation and Sustains Phospho-JAK2 Action in MedB-1 Mediastinal Lymphoma Line.

Peter Moller, MD
Journal: Blood
Blood (2004) 104 (11): 2283.
https://doi.org/10.1182/blood.V104.11.2283.2283
Published: 2004